1813 related articles for article (PubMed ID: 35431501)
1. Impaired coagulation, liver dysfunction and COVID-19: Discovering an intriguing relationship.
D'Ardes D; Boccatonda A; Cocco G; Fabiani S; Rossi I; Bucci M; Guagnano MT; Schiavone C; Cipollone F
World J Gastroenterol; 2022 Mar; 28(11):1102-1112. PubMed ID: 35431501
[TBL] [Abstract][Full Text] [Related]
2. COVID-19 coagulopathy - what should we treat?
Chowdary P
Exp Physiol; 2022 Jul; 107(7):749-758. PubMed ID: 35733235
[TBL] [Abstract][Full Text] [Related]
3. The coagulopathy, endotheliopathy, and vasculitis of COVID-19.
Iba T; Connors JM; Levy JH
Inflamm Res; 2020 Dec; 69(12):1181-1189. PubMed ID: 32918567
[TBL] [Abstract][Full Text] [Related]
4. Liver injury in COVID-19 and IL-6 trans-signaling-induced endotheliopathy.
McConnell MJ; Kawaguchi N; Kondo R; Sonzogni A; Licini L; Valle C; Bonaffini PA; Sironi S; Alessio MG; Previtali G; Seghezzi M; Zhang X; Lee AI; Pine AB; Chun HJ; Zhang X; Fernandez-Hernando C; Qing H; Wang A; Price C; Sun Z; Utsumi T; Hwa J; Strazzabosco M; Iwakiri Y
J Hepatol; 2021 Sep; 75(3):647-658. PubMed ID: 33991637
[TBL] [Abstract][Full Text] [Related]
5. COVID-19 Infection: Viral Macro- and Micro-Vascular Coagulopathy and Thromboembolism/Prophylactic and Therapeutic Management.
Manolis AS; Manolis TA; Manolis AA; Papatheou D; Melita H
J Cardiovasc Pharmacol Ther; 2021 Jan; 26(1):12-24. PubMed ID: 32924567
[TBL] [Abstract][Full Text] [Related]
6. Pathomechanisms Underlying Hypoxemia in Two COVID-19-Associated Acute Respiratory Distress Syndrome Phenotypes: Insights From Thrombosis and Hemostasis.
Gando S; Wada T
Shock; 2022 Jan; 57(1):1-6. PubMed ID: 34172612
[TBL] [Abstract][Full Text] [Related]
7. Venous thrombosis epidemiology, pathophysiology, and anticoagulant therapies and trials in severe acute respiratory syndrome coronavirus 2 infection.
Obi AT; Barnes GD; Napolitano LM; Henke PK; Wakefield TW
J Vasc Surg Venous Lymphat Disord; 2021 Jan; 9(1):23-35. PubMed ID: 32916371
[TBL] [Abstract][Full Text] [Related]
8. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
Stratton CW; Tang YW; Lu H
J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
[TBL] [Abstract][Full Text] [Related]
9. The Impact of COVID-19 Disease on Platelets and Coagulation.
Wool GD; Miller JL
Pathobiology; 2021; 88(1):15-27. PubMed ID: 33049751
[TBL] [Abstract][Full Text] [Related]
10. IL-1 induces throboxane-A2 (TxA2) in COVID-19 causing inflammation and micro-thrombi: inhibitory effect of the IL-1 receptor antagonist (IL-1Ra).
Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G; Toniato E
J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1623-1627. PubMed ID: 32744052
[TBL] [Abstract][Full Text] [Related]
11. Prothrombotic Phenotype in COVID-19: Focus on Platelets.
Barale C; Melchionda E; Morotti A; Russo I
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948438
[TBL] [Abstract][Full Text] [Related]
12. Viscoelastic Tests in the Evaluation of Haemostasis Disturbances in SARS-CoV2 Infection.
Rodrigues A; Seara Sevivas T; Leal Pereira C; Caiado A; Robalo Nunes A
Acta Med Port; 2021 Jan; 34(1):44-55. PubMed ID: 33159728
[TBL] [Abstract][Full Text] [Related]
13. [Peculiarities of blood coagulation disorders in patients with COVID-19].
Evtugina NG; Sannikova SS; Peshkova AD; Safiullina SI; Andrianova IA; Tarasova GR; Khabirova AI; Rumyantsev AG; Ataullakhanov FI; Litvinov RI
Ter Arkh; 2021 Nov; 93(11):1255-1263. PubMed ID: 36286646
[TBL] [Abstract][Full Text] [Related]
14. Is COVID Evolution Due to Occurrence of Pulmonary Vascular Thrombosis?
Saba L; Sverzellati N
J Thorac Imaging; 2020 Nov; 35(6):344-345. PubMed ID: 32349055
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 and coagulation disorders in different organs.
Vinayagam S; Sattu K
Life Sci; 2020 Nov; 260():118431. PubMed ID: 32946915
[TBL] [Abstract][Full Text] [Related]
16. COVID-19-related laboratory coagulation findings.
Devreese KMJ
Int J Lab Hematol; 2021 Jul; 43 Suppl 1(Suppl 1):36-42. PubMed ID: 34288440
[TBL] [Abstract][Full Text] [Related]
17. Coagulation Abnormalities and Thrombosis in Patients Infected With SARS-CoV-2 and Other Pandemic Viruses.
Mackman N; Antoniak S; Wolberg AS; Kasthuri R; Key NS
Arterioscler Thromb Vasc Biol; 2020 Sep; 40(9):2033-2044. PubMed ID: 32657623
[TBL] [Abstract][Full Text] [Related]
18. COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects.
Smadja DM; Mentzer SJ; Fontenay M; Laffan MA; Ackermann M; Helms J; Jonigk D; Chocron R; Pier GB; Gendron N; Pons S; Diehl JL; Margadant C; Guerin C; Huijbers EJM; Philippe A; Chapuis N; Nowak-Sliwinska P; Karagiannidis C; Sanchez O; Kümpers P; Skurnik D; Randi AM; Griffioen AW
Angiogenesis; 2021 Nov; 24(4):755-788. PubMed ID: 34184164
[TBL] [Abstract][Full Text] [Related]
19. COVID-19-induced coagulopathy: Experience, achievements, prospects.
Dubey L; Dorosh O; Dubey N; Doan S; Kozishkurt O; Duzenko O; Kozlova O; Ievtukh V; Ladny JR; Pruc M; Szarpak L; Pukach J
Cardiol J; 2023; 30(3):453-461. PubMed ID: 36588310
[TBL] [Abstract][Full Text] [Related]
20. Interrelationship between COVID-19 and Coagulopathy: Pathophysiological and Clinical Evidence.
Ragnoli B; Da Re B; Galantino A; Kette S; Salotti A; Malerba M
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
